Table 1. Summary of datasets.
| Species | Dataset | SRA Study ID/Reference | Nsamples | Temporal range | Geographic range | Sampling approach |
|---|---|---|---|---|---|---|
| N. gonorrhoeae | 1 | ERP011192 | 886 | 2011–2015 | New York, NY (US) | Survey from citywide clinics |
| 2 | ERP008891, ERP001405, ERP000144 [23] |
1102 | 2000–2013 | National (US) | Survey from nationwide clinics; male patients only; enriched for ESC and AZM resistance | |
| 3 | SRP065041, ERP000144, ERP001405, ERP008891, SRP072971 [30] |
671 | 2004–2014 | International (UK, Canada, US) | Surveys from Brighton, UK [55] and nationwide sites in Canada [56, 57] and the US [23, 58]; Canadian samples enriched for CRO and AZM resistance; US samples enriched for ESC and AZM resistance; US samples from male patients only | |
| 4 | SRP050190, SRP065041 [56, 57] |
383 | 1989–2014 | National (Canada) | Surveys from nationwide sites in Canada; enriched for CRO and AZM resistance | |
| 5 | ERP010312 [28] |
714 | 2013 | International (Europe) | Survey from clinics and hospitals across 21 European countries | |
| 6 | DRP004052 [29] |
204 | 2015 | National (Japan) | Survey from clinics in Kyoto and Osaka; male patients only | |
| 7 | SRP111927 [59] |
398 | 2014–2015 | National (New Zealand) | Survey from nationwide diagnostic labs | |
| K. pneumoniae | 8 | SRP102664 [14] |
1560 | 2011–2017 | Houston, TX (US) | Survey from citywide hospital system; enriched for β-lactam resistance |
| A. baumannii | 9 | SRP065910 [60] |
702 | 2000–2012 | National (US) | Survey from clinics and hospitals within the US military healthcare system |
ESC, extended spectrum cephalosporin; AZM, azithromycin; CRO, ceftriaxone